EF-2 Activators refer to compounds that activate elongation factor 2 (EF-2), a crucial protein involved in the protein synthesis machinery within cells. Elongation factor 2 plays an essential role in the elongation phase of protein synthesis in eukaryotes. This factor is responsible for promoting the translocation of the ribosome along the mRNA, a step that is necessary for the addition of new amino acids to the growing polypeptide chain during the synthesis of proteins. Without EF-2's pivotal role in this process, the ribosome would not be able to advance along the mRNA, stalling protein synthesis.
The precise molecular mechanisms by which EF-2 activators exert their activating effect remain a topic of interest. Activation of EF-2 can influence the rate and efficiency of protein synthesis, making these activators crucial for understanding the intricacies of translational control within cells. Like other components of the cellular protein synthesis machinery, the activity of EF-2 is regulated by a series of phosphorylation events. EF-2 activators may act by modulating these post-translational modifications, though the exact pathways and modulatory effects can vary among different EF-2 activators. Furthermore, given the broad importance of protein synthesis in cellular function, EF-2 activators can have profound impacts on cellular physiology, including growth, differentiation, and response to environmental cues. The study of EF-2 activators not only enhances our understanding of translational control but also provides insights into the broader aspects of cellular biology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
A natural compound found in bacteria, rapamycin specifically inhibits mTORC1, a complex within the mTOR pathway. By inhibiting mTORC1, it can reduce protein synthesis. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
A commonly used compound for type 2 diabetes, metformin activates AMPK. As AMPK can activate eEF2K, which in turn inhibits EF-2, metformin might indirectly reduce EF-2 activity. | ||||||
AICA-Riboside, 5′-Phosphate | 3031-94-5 | sc-202448B sc-202448C sc-202448 sc-202448A | 5 mg 10 mg 50 mg 100 mg | $184.00 $281.00 $505.00 $938.00 | 1 | |
A known activator of AMPK, which, like metformin, can indirectly influence EF-2 activity. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
It has been shown to inhibit mTOR in certain contexts, which can indirectly affect EF-2. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Found in grapes and red wine, this compound is known to activate AMPK, potentially influencing EF-2 activity. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $211.00 | 8 | |
An inhibitor of both PI3K and mTOR, it can modulate the activity of the mTOR pathway and hence potentially EF-2. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $245.00 | 7 | |
A potent and selective mTOR inhibitor that affects both mTORC1 and mTORC2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that indirectly reduces mTOR activation, which can potentially influence EF-2 activity. | ||||||
Azithromycin | 83905-01-5 | sc-254949 sc-254949A sc-254949B sc-254949C sc-254949D | 25 mg 50 mg 500 mg 1 g 5 g | $52.00 $103.00 $260.00 $364.00 $728.00 | 17 | |
Some studies suggest that this antibiotic can influence mTOR signaling, potentially affecting EF-2 indirectly. | ||||||
Perifosine | 157716-52-4 | sc-364571 sc-364571A | 5 mg 10 mg | $188.00 $327.00 | 1 | |
An alkylphospholipid that inhibits AKT and several other kinases. Since AKT is upstream of mTOR, perifosine might indirectly influence EF-2. | ||||||